Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France.

Jousset, Agnès B; Bouabdallah, Laura; Birer, Aurélien; Rosinski-Chupin, Isabelle; Mariet, Jean-François; Oueslati, Saoussen; Emeraud, Cécile; Girlich, Delphine; Glaser, Philippe; Naas, Thierry; Bonnin, Rémy A; Dortet, Laurent

Jousset, Agnès B; Bouabdallah, Laura; Birer, Aurélien; Rosinski-Chupin, Isabelle; Mariet, Jean-François; Oueslati, Saoussen; Emeraud, Cécile; Girlich, Delphine; Glaser, Philippe; Naas, Thierry; Bonnin, Rémy A; Dortet, Laurent.

Emerg Infect Dis ; 29(9): 1877-1881, 2023 09.

Article en En | MEDLINE | ID: mdl-37610183

ABSTRACT

ABSTRACT

Cefiderocol resistance is increasingly reported in New Delhi metallo-ß-lactamase-producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued genomic surveillance of carbapenem-resistant Enterobacterales could clarify prevalence of cefiderocol-resistant E. coli in Europe.

Asunto(s)

Escherichia coli; Gammaproteobacteria; Escherichia coli/genética; Francia/epidemiología; Europa (Continente); Cefalosporinas/farmacología; Cefiderocol

Palabras clave

Enterobacterales; Escherichia coli; France; antimicrobial resistance; bacteria; carbapenemase; cefiderocol; enteric infections; epidemiology; food safety

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Gammaproteobacteria / Escherichia coli Tipo de estudio: Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Emerg Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google